Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Best Practices for Design and Operation of Multiproduct Manufacturing Facilities

February 02, 2020

Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.

Building Strategic Relationships with CROs

February 01, 2020

How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.

Digitalization: A CDMO’s Perspective

February 01, 2020

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.

Sourcing Success in Cell and Gene Therapy Development

February 01, 2020

As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.

More Capacity and Technology Translate to More Options

February 01, 2020

The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.

Growth in Biologics Market Inspires Outsourcing

February 01, 2020

CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.

PPD Launches IPO

January 27, 2020

Drug development contract services company PPD announces initial public offering.

FDA Revises Compounding Guidance

January 22, 2020

FDA revised the guidance after industry feedback and to clarify CGMP requirements for outsourcing facility operations.

Catalent Biologics Announces Senior Leadership Appointments

January 16, 2020

Karen Flynn rejoins Catalent as president of biologics operations; regional presidents named for US and Europe.

Catalent Launches Direct-to-Patient Clinical Supply Services

January 15, 2020

Catalent’s FlexDirect service offers sponsors multiple delivery options from a single inventory.